| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/15/2004 | US20040139499 encoded by a nucleic acid isolated from a Euphorbia lagascae developing seed cDNA library; chimeras; genetic engineering |
| 07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |
| 07/15/2004 | US20040138420 Fluorescent proteins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138413 Compositions and methods for immunoaffinity purification |
| 07/15/2004 | US20040138154 Solid surface for biomolecule delivery and high-throughput assay |
| 07/15/2004 | US20040138150 Motilide compounds |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040137632 Method for more efficient electroporation |
| 07/15/2004 | US20040137626 AAV ITR-mediated modulation |
| 07/15/2004 | US20040137602 Propagating pleurotus fruiting for use in treatment of hypertension, hyperlipidemia and obesity |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137600 Propagating nematode parasitic bacteria for use as tools in generating disease resistant crops; biological pest control |
| 07/15/2004 | US20040137598 Peptidylarginine deiminase 6 |
| 07/15/2004 | US20040137595 Mfq-111, a novel human gtpase like protein |
| 07/15/2004 | US20040137594 Transformed cell with enhanced sensitivity to antifungal compound and use thereof |
| 07/15/2004 | US20040137592 Comprises phosphatidyl inositol kinase related protein for use in the identification of modulators for treatment of cystic fibrosis and/or muscular disorders |
| 07/15/2004 | US20040137591 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 07/15/2004 | US20040137590 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 07/15/2004 | US20040137586 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
| 07/15/2004 | US20040137584 Biotin biosynthetic genes |
| 07/15/2004 | US20040137583 high optical density [OD] from the group selected from an algae whose life cycle has sexual/asexual reproduction and vegetative propagation: Galaxaura oblongata, Halymenia ceylanica, Helminthocladia australis, and Porphyra dentata |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137567 using a gene and a protein which are required for enabling or enhancing the activity expression as well as a method of efficiently producing a coenzyme Q having a long-chain isoprenoid in its side chain |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137560 comprises rupturing a yeast cell in a frozen state and and mashing in a mortar with a pestle followed by dialysis; kits |
| 07/15/2004 | US20040137558 by using a culture of a microbe having an ability to produce a dipeptide from an amino acid ester and an amino acid |
| 07/15/2004 | US20040137556 Yeast strains autonomously producing steroids |
| 07/15/2004 | US20040137555 for producing androst-4-ene-3,17-dione (AD) and androsta-1,4-diene-3,17-dione (ADD) by fermentation; for mass production |
| 07/15/2004 | US20040137554 Diagnosis and treatment of bacterial infections |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137505 for use in cleaning products and detergents |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137487 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137447 Human sphingosine-1-phosphate phosphatase |
| 07/15/2004 | US20040137443 Novel clock gene promoter |
| 07/15/2004 | US20040137438 Encoding transporter of the inner mitochondrial membrane; able to inhibit the expression of a MCF (mitochondrial carrier family) in a host cell in antisense orientation to a promoter; use in modification of transport properties |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137017 amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment of the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment, where in Ser-63 and Arg-192 are replaced with another amino acid |
| 07/15/2004 | US20040137016 glycosylated or is partially glycosylated ; mutant pre-S in which one or both asparagines of a wild-type pre-S at amino acid position 15 or 123 are substituted by specific amino acids |
| 07/15/2004 | US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/15/2004 | US20040137009 DNA encoding a derivative of a human interferon- alpha selected from DNA encoding a protein in which one or more amino acid residues of the protein encoded by the above DNA have been replaced, deleted, and/or added |
| 07/15/2004 | US20040137007 includes polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136964 Substrates containing a trichoderma asperellum strain for biological control of fusarium and rhizoctonia |
| 07/15/2004 | DE10352801A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Methanol-Assimilierenden Bakterien A method for producing L-amino acids using methanol-assimilating bacteria |
| 07/15/2004 | DE10258885A1 Verfahren zur Generierung eines gentechnisch veränderten Organismus Method for generating a genetically modified organism |
| 07/15/2004 | CA2511553A1 Process for producing dipeptides |
| 07/15/2004 | CA2511359A1 Steroid receptor modulation of gene expression |
| 07/15/2004 | CA2509702A1 Mutations affecting plasmid copy number |
| 07/15/2004 | CA2508948A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 07/14/2004 | EP1437411A1 Glucose dehydrogenase |
| 07/14/2004 | EP1437405A1 Gene overexpression system |
| 07/14/2004 | EP1437401A1 Oxidoreductase |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437399A1 Yeast extract solution, its preparation and use for cell-free protein synthesis |
| 07/14/2004 | EP1437363A1 Drug transporter and use thereof |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436400A1 Multi-cistronic vectors for gene transfer protocols |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436396A2 A human g protein coupled receptor |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |
| 07/14/2004 | EP1436388A2 Novel human proteases and polynucleotides encoding the same |
| 07/14/2004 | EP1436387A2 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n-acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 07/14/2004 | EP1436386A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 07/14/2004 | EP1436385A2 Dna polymerases and mutants thereof |
| 07/14/2004 | EP1436384A2 Mutated abl kinase domains |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436380A2 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436326A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436325A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 07/14/2004 | EP1436309A2 Bgl3 beta-glucosidase and nucleic acids encoding the same |
| 07/14/2004 | EP1436234A1 Organic waste treatment |
| 07/14/2004 | EP1436233A2 Metal binding proteins and associated methods |
| 07/14/2004 | EP1436058A1 Separation medium, its preparation and its use |
| 07/14/2004 | EP1436056A2 Macroporous gel, its preparation and its use |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/14/2004 | EP0912725B1 Glycosidase enzymes |
| 07/14/2004 | EP0837943B1 In vivo assays for modulators of sterol biosynthesis |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | CN1513059A Enzymes having alpha amylase activity and method of use thereof |
| 07/14/2004 | CN1513058A Secretory streptococcus pneumoniae proteins |
| 07/14/2004 | CN1513057A 宿主微生物 Host microorganisms |
| 07/14/2004 | CN1513056A Production of bioarailable folic acid |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512838A Preventing corrosion with beneficial biofilms |